The Behavioral Drivers of Dermatology Treatment Adherence and Persistence

Unlike many chronic conditions, adherence in dermatology is heavily influenced by patient perceptions and symptom improvement.

Dermatological conditions require ongoing management, yet patients often disengage from therapy when symptoms improve. Many support programs focus on reminders, but real-world data suggest the challenge is far more complex.

After analyzing 130+ behavioral signals per patient across millions of managed doses and more than 12 years of real-world adherence data, Medisafe identified predictable behavioral patterns that influence whether patients stay engaged with therapy over time. The findings reveal that long-term patient persistence isn’t shaped by forgetfulness, but rather a combination of behavioral, environmental, and treatment-related factors.

Dermatology Adherence Is Behavioral

Across dermatology patient populations, Medisafe's analysis uncovered several notable trends:

• Adherence varies significantly across countries and regions.
• Dosage fluctuates throughout the week, with adherence rates varying by day and time of day.
• Persistence differs across dermatological conditions and treatment types.
• Nearly 30% of missed doses occur because patients don't believe treatment is necessary.

Adherence challenges often stem from the everyday experience of managing a chronic skin condition, not simply a failure to remember a dose.

By understanding the behavioral signals that influence persistence, patient support programs can move beyond generic reminders and deliver more meaningful engagement across their entire portfolio.

Why Traditional Adherence Programs Struggle

Many patient support programs rely on standardized outreach, static reminders, and broad educational campaigns. The challenge is that adherence risk is highly individualized.

A patient managing psoriasis may face different barriers than someone living with eczema. A patient who believes treatment is no longer necessary requires a different intervention than someone who simply forgot to take a dose.

Without visibility into these behavioral drivers, brand teams miss opportunities to engage patients before adherence begins to decline.

From Behavioral Data to Better Patient Engagement

Medisafe's engagement engine is built on real-world behavioral data collected across millions of patient journeys.

By identifying therapy-specific adherence patterns and behavioral risk signals, Medisafe helps pharmaceutical organizations deliver more personalized interventions, optimize engagement timing, and support patients throughout the treatment journey in real-time.

The result is a more proactive approach to patient support designed to strengthen adherence, improve persistence, and maximize the value of dermatology therapies.

New Insights Into Dermatology Patient Behavior

Our latest analysis explores how treatment complexity, daily routines, therapy type, and social support influence adherence across metabolic patient populations.

The findings offer practical insights for pharmaceutical teams looking to strengthen patient support programs, improve persistence, and maximize the impact of dermatology therapies.

‍